' Incredibly Exciting ' : Diabetes Drug With CV Benefits ' Incredibly Exciting ' : Diabetes Drug With CV Benefits
The FDA ' s recent addition of a cardiovascular indication for diabetes drug empagliflozin is a significant milestone in diabetes care, says Dr Anne Peters.Medscape Diabetes & Endocrinology
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology Commentary Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Empagliflozin | Endocrinology | Heart | Jardiance